In a study by Nagashima et al. [66] investigating the potential possibility of gastrointestinal hormones against protection from atherosclerosis, active forms of incretins—GLP-1(7–36)amide and GIP(1–42)amide were proved to exert an anti-atherogenic effect. The gene discussed is GIP; the disease is atherosclerosis.